SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The company witnessed a 14.17% growth in the revenue at Rs. 9135.10 millions for the quarter ended December 2024 as compared to Rs. 8001.00 millions during the year-ago period.The Company has registered profit of Rs. 1563.90  millions for the quarter ended December 2024, a growth of 22.26%  over Rs. 1279.20 millions millions achieved in the corresponding quarter of last year.Operating Profit saw a handsome growth to 2525.60 millions from 2213.00 millions in the quarter ended December 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 9135.10 8001.00 14.17 28215.80 24894.40 13.34 32986.40 28841.60 14.37
Other Income 71.60 66.10 8.32 212.10 185.80 14.16 346.80 86.50 300.92
PBIDT 2525.60 2213.00 14.13 8081.70 7029.40 14.97 9141.00 6733.40 35.76
Interest 18.50 115.20 -83.94 81.90 321.90 -74.56 405.20 343.10 18.10
PBDT 2507.10 2097.80 19.51 7999.80 6707.50 19.27 8735.80 6390.30 36.70
Depreciation 411.80 333.70 23.40 1220.40 955.20 27.76 1352.40 1119.90 20.76
PBT 2095.30 1764.10 18.77 6779.40 5752.30 17.86 7383.40 5270.40 40.09
TAX 531.40 484.90 9.59 1752.00 1577.20 11.08 1949.80 1381.50 41.14
Deferred Tax 96.90 135.80 -28.65 271.00 401.50 -32.50 494.90 548.00 -9.69
PAT 1563.90 1279.20 22.26 5027.40 4175.10 20.41 5433.60 3888.90 39.72
Equity 155.50 155.00 0.32 155.50 155.00 0.32 155.20 154.80 0.26
PBIDTM(%) 27.65 27.66 -0.04 28.64 28.24 1.44 27.71 23.35 18.70

JB Chem & Pharma Share Price

1978.00 -20.65 (-1.03%)
15-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1696.65
Dr. Reddys Lab 1218.30
Cipla 1226.65
Zydus Lifesciences 936.00
Lupin 2339.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×